GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Penumbra PEN · USD

Health Care · US listing · 🇺🇸 United States

Compare

321.85

+0.83%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$1.40bn

FY2016FY2025

Net income

$177.7m

FY2016FY2025

Free cash flow

$174.9m

FY2016FY2025

Shareholders' equity

$1.43bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$1.40bn$1.19bn$1.06bn$847.1m$747.6m$560.4m$547.4m$444.9m$333.8m$263.3m
Gross profit$942.4m$755.0m$682.6m$535.2m$475.4m$338.2m$372.0m$292.5m$217.1m$170.8m
Research and development$89.8m$94.8m$84.4m$79.4m$104.6m$90.0m$51.7m$36.2m$31.7m$23.9m
Operating income$189.2m$86.2m$73.6m$6.1m−$7.5m−$38.9m$47.5m−$852,000$1.2m−$1.4m
Net income$177.7m$14.0m$91.0m−$2.0m$2.6m−$19.3m$48.5m$6.6m$4.7m$14.8m
Diluted earnings per share4.510.362.31-0.050.07-0.511.330.180.130.48

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$1.83bn$1.53bn$1.56bn$1.37bn$1.24bn$823.0m$665.9m$515.0m$476.7m$308.3m
Cash and short-term investments$544.8m$340.1m$289.2m$188.0m$254.9m$264.8m$189.4m$200.9m$214.6m$128.8m
Total liabilities$398.9m$382.3m$377.4m$372.0m$290.3m$185.2m$180.3m$92.6m$76.3m$41.7m
Debt$36.9m$24.1m$25.9m$26.8m$28.2m$28.4m$30.9m———
Shareholders' equity$1.43bn$1.15bn$1.18bn$998.9m$953.9m$641.5m$485.9m$422.2m$400.4m$266.5m
Shares outstanding39m39m39m39m37m37m36m36m36m31m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$238.7m$168.5m$97.3m−$55.7m$9.5m−$33.2m$26.7m$28.8m$12.7m−$12.8m
Capital spending−$63.7m−$21.2m−$15.2m−$19.3m−$21.2m−$24.8m−$22.1m−$9.6m−$15.0m−$13.6m
Free cash flow$174.9m$147.3m$82.1m−$75.0m−$11.7m−$58.0m$4.5m$19.2m−$2.3m−$26.4m
Dividends paid———−$8.0m−$15.8m−$10.1m−$18.5m———

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$390.0m$374.8m$385.4m$354.7m$339.5m$324.1m$315.5m$301.0m
Gross profit$264.9m$253.4m$262.1m$240.4m$224.0m$215.9m$210.7m$200.3m
Operating income$41.0m$38.2m$59.2m$48.8m$40.8m$40.3m$42.8m$35.4m
Net income$34.8m$32.6m$47.3m$45.9m$45.3m$39.2m$33.7m$29.5m
Diluted earnings per share0.880.821.201.161.151.000.860.75
Cash from operations$46.0m$86.0m$86.0m$58.0m$44.0m$48.0m$51.0m$56.0m
Capital spending−$13.0m−$13.0m−$18.0m−$16.0m−$15.0m−$13.0m−$5.0m−$5.0m
Free cash flow$33.0m$73.0m$68.0m$42.0m$29.0m$35.0m$46.0m$51.0m
Total assets$1.97bn$1.90bn$1.83bn$1.74bn$1.67bn$1.59bn$1.53bn$1.48bn
Cash and short-term investments$658.8m$615.7m$544.8m$470.3m$424.6m$378.8m$340.1m$291.0m
Debt$16.8m$16.5m$36.9m$36.7m$37.0m$36.0m$36.3m$36.7m
Shareholders' equity$1.53bn$1.47bn$1.43bn$1.36bn$1.29bn$1.21bn$1.15bn$1.10bn

Financial ratios

Data as of 2 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin67.1%63.2%64.5%63.2%63.6%60.3%
Operating margin13.5%7.2%6.9%0.7%-1.0%-6.9%
Net margin12.7%1.2%8.6%-0.2%0.4%-3.4%
Return on equity12.4%1.2%7.7%-0.2%0.3%-3.0%
Return on assets9.7%0.9%5.8%-0.1%0.2%-2.3%
Free cash flow yield2.4%1.5%0.9%-0.3%0.3%-0.1%
Revenue growth17.5%12.9%25.0%13.3%33.4%2.4%
Earnings growth1168.1%-84.6%-4643.2%-176.3%-113.6%-139.7%
Current ratio6.64x6.01x6.06x5.21x5.53x5.83x
Debt to equity0.01x0.01x0.01x0.01x0.01x0.01x
Equity ratio78.2%75.1%75.8%72.9%76.7%77.9%
Interest coverage144.35x60.81x42.29x3.48x-0.47x-2.24x
R&D as a share of sales6.4%7.9%8.0%9.4%14.0%16.1%
Buybacks as a share of market value-0.3%0.1%-1.0%-3.9%0.0%-3.1%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue18.3%20.2%22.4%
Operating income214.5%—46.4%
Net income——54.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin65.3%64.7%64.2%64.7%
Operating margin10.6%7.9%5.3%4.7%
Net margin7.4%6.2%4.5%4.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings68.9—108.7-4322.2—-340.4123.1——133.7
Price to sales8.77.89.310.214.411.710.99.910.17.5

Market value over time

30 Nov 2016 to 1 Oct 2026, in USD

$2.09bn$12.58bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return32%-5%15%-12%35%16%37%21%52%14%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.